The global pentavalent antimonials market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Pentavalent antimonials are a class of compounds used for the treatment of leishmaniasis. Antimonials have largely been used for the treatment of cutaneous and mucocutaneous leishmaniasis. These are widely available for use as an aqueous solution for intravenous or intramuscular use. Pentavalent antimonials are available as Sodium stibogluconate and meglumine antimoniate. Advances in existing anti-leishmanial drugs which further result in effective and safer formulations, have been witnessed as the latest market trend which is primarily driving the market growth. For instance, as per the data of the Drugs for Neglected Diseases initiative (DNDi), 2 new chemical entities labelled as DNDI-6148 and DNDI-0690 were introduced into the preclinical development stage for the treatment of visceral and cutaneous leishmaniasis in 2016.
To Request a Sample of our Report on Global Pentavalent Antimonials Market: https://www.omrglobal.com/request-sample/pentavalent-antimonials-market
Immunomodulator- CpG-D35, is also in a pre-clinical development stage, which is proposed to be used as an adjunct apart from the main drug therapy to treat cutaneous leishmaniasis. Such developments and advancements are anticipated to augment the global market growth. Additionally, several initiatives and government efforts have been witnessed to increase visceral leishmaniasis surveillance, diagnosis, vector control, as well as its treatment, which ultimately, is projected to positively impact the market growth. For instance, the World Health Organization (WHO) had launched an action plan for reducing the impact of Neglected Tropical Diseases (NTDs), including visceral leishmaniasis in 2012.
Some key players operating in the market include Sanofi S.A. and GlaxoSmithKline plc, among others. The market players are focusing on strengthening their position in the market by adopting various strategies such as mergers and acquisitions, partnerships, collaborations, new product launches and development in the existing product portfolio, and so on. For instance, in 2016, the WHO and Gilead Sciences, Inc. signed an agreement to donate 380,400 vials of AmBisome (liposomal amphotericin B), extending their previous agreement from 2016 to 2021. This five-year collaboration aided by the funding of $20 million by Gilead Sciences, Inc. is aimed to provide access to diagnosis and treatment to the populations affected by visceral leishmaniasis in key endemic countries, majorly India, Ethiopia, South Sudan, Nepal, Bangladesh, and Sudan.
Market Coverage
· The market number available for – 2020-2027
· Base year- 2020
· Forecast period- 2021-2027
· Segment Covered
· Regions Covered- Globally
· Competitive Landscape: Sanofi S.A. and GlaxoSmithKline plc, among others.
(Get 15% Discount on Buying this Report)
A full Report of Global Pentavalent Antimonials Market is Available at: https://www.omrglobal.com/industry-reports/pentavalent-antimonials-market
Global Pentavalent Antimonials Market Report by Segment
By Type
• Sodium Stibogluconate
• Meglumine Antimoniate
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Global Pentavalent Antimonials Market by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
